AirSculpt Technologies, Inc.

Greetings. Welcome to the Aresculpt Technologies, Inc. second quarter 2023 earnings call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the call, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. At this time, I would like to hand the call over to Dennis Dean, Chief Financial Officer. Thank you. You may begin.

Good morning, everyone. and thanks for joining us to discuss AirSculpt Technologies results for the second quarter. Joining me on the call today is the company's founder and executive chairman, Dr. Aaron Rollins, and chief executive officer, Todd Magazine. Before we begin, I would like to remind you that this conference call may include forward-looking statements. These statements may include our future expectations regarding financial results and guidance, market opportunities, and our growth. Risk and uncertainties that may impact these statements and could cause actual future results to differ materially from currently projected results are described in this morning's press release and the reports we will file with the SEC, all of which can be found on our website at investors.elitebodysculpture.com. We undertake no obligation to revise or update any forward-looking statements or information except as required by law. During our call today, we will also reference certain non-GAAP financial measures. We use non-GAAP measures in some of our financial discussions as we believe they more accurately represent the true operational performance and underlying results of our business. A reconciliation of these measures can be found in our earnings release as filed this morning and in our most recent 10-Q when filed, which will also be available on our website. With that, I'll turn the call over to Erin.

Thank you, Dennis, and good morning to everyone joining the call. Our results for the second quarter were very strong and further demonstrate the demand for AirSculpt. Todd and Dennis will provide more specific details about our performance in their remarks, but let me say that I'm so pleased with how we have grown the company to the place it is today. We have performed over 40,000 procedures in our history and are now offering AirSculpt in three countries. I believe we are well positioned for continued long-term growth and significant shareholder value creation. As I shared previously, I have shifted more of my time to clinical excellence and innovation. On the innovation front, we recently rolled out Aeroscope Lift, a facial fat transfer procedure that can eliminate wrinkles, restore loss volume to areas of the face, and provide more volumes in the lips. As you know, the broader filler market is over $4 billion, which expands our already significant TAM to over $11 billion. Our new procedure offers significant benefits compared to artificial facial fillers. We use the client's own fat, which I refer to as liquid gold, as the actual filler material. This increases the body's acceptance of the filler and provides a more natural, permanent, and consistent result. It's all highly concentrated with the client's own stem cells. Artificial fillers, which, as you may have read recently, are resulting in adverse hypersensitivity reactions, lymphatic drainage issues, and may not be fully absorbed by the body. Artificial facial filler injections must be touched up every 12 to 8 months, whereas our procedure is one and done. It's permanent. That's both a convenience and a value driver for our clients. Bottom line, with the addition of AirScope Lift, we are broadening our offering as well as our competitive mode. We have rolled out this procedure in about a third of our centers, including London, and will continue to expand it to the rest of the fleet over the coming months as we train up our doctors. We are starting to test more new procedures and working on many other exciting new and enhanced innovation initiatives that I will share at a later date. Overall, our team is delivering consistent performance and executing on our key growth areas. Our strategy continues to focus on strengthening the Aeroscope brand, accelerating our store openings, and further enhancing our profitability as we scale our business both domestically and internationally. With that, let me now turn things over to Todd.